Nobel Prize, Jim Allison, Mr. Ellison discussed on On Point with Tom Ashbrook | Podcasts

Automatic TRANSCRIPT

The other scientists who've been working on therapies and cancer, because this is one thing that I think you know, the Nobel prize does a great job at at acknowledging great work and focusing, you know the public's broader attention on things that are happening in science and medicine in particular. But. Hope you don't mind me saying, but I presume you're not the only person who's had a big impact in this field. No, I'm the way that science and there I work in works. As we, we have students and postdoctoral fellows, and you know, we direct their efforts and as a team, you know, approach things and I, it would be I'd have to give you a long list people that contributed to this, but you know. They mothers work was done to foundation for the stuff was done in the mid nineties, actually massive graduate students in my lab at the university of California, Berkeley at the time, and I have to give them a lot of credit most notably, guiding max krummel, who was the guy that did the cool experiments that showed that seeks for it was the breaks on the immune system. Britain Yuli. I, I mean to that point, there's a lot of their many people out there working on this. There's a labs across the United States and around the world where what do you think is the best thing that the public could do to further support enhance, you know, advance this research. So I think it's incredibly important that the public understand the value of participating in clinical trials. Clinical trials, research working with physician researchers who are trying to advance these new news therapies. All the wonderful discoveries in the laboratory don't don't mean much to human beings unless we can have patience, you know, partner with us to really test them and study them. So that's one way where people can make a tremendous difference in the world in hopefully for themselves. But also even if not for the world and future cancer patients, you know. And then finally, a lot of research is supported by by the by the government and continued public support for the type of research that has led to these breakthroughs that comes out of our public funding is really, really something we'd like to see our our citizens continued to advocate for well, Monica, Burton Yolly president of the American society for Clinical Oncology and chief of the division of surgical oncology at danafarber, Brigham and women's hospital cancer center. Thank you so much for joining us. Thanks magnates been great. And Jim Allison, the two thousand eighteen Nobel prize winner in physiology or medicine on a award that he shares with soup Honjo of Kyoto University. Jim Allison is also chair of the department of immunology at MD Anderson Cancer Center. Mr. Ellison. Thank you so much for joining us today and congratulations on the Nobel prize and all your research. Thank you so very. Much. Thank you. Thank you so much the chance to do this and by the way folks, if you've been wondering why I've been calling Jamal's and Mistrals Dr Ellison he is Jim Elson PHD but our journalistic standards here at NPR say, MD's get called doctors, PHD's get PHD's, I guess. So that's the quick explanation there, but go to our website on point, radio dot org. If you've got thoughts about cancer treatments today and immuno therapies as well, I'm gonna trucker body. This is on point.

Coming up next